Gavin MacBeath
Algemeen Directeur bij TSCAN THERAPEUTICS, INC.
Vermogen: 362 801 $ op 30-04-2024
Actieve functies van Gavin MacBeath
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur/Bestuurslid | 24-05-2023 | - |
| Algemeen Directeur | 28-03-2023 | - | |
| Operationeel Directeur | 01-06-2022 | 24-05-2023 | |
| Hoofd Techniek/Wetenschap/O&O | 01-12-2018 | 24-05-2023 | |
| Financieel Directeur/CFO | 21-07-2023 | 29-01-2024 |
Loopbaan van Gavin MacBeath
Eerdere bekende functies van Gavin MacBeath
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ABPRO CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-03-2017 | 01-07-2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Oprichter | 01-01-1993 | 01-09-2017 |
| Corporate Officer/Principal | 13-07-2011 | 01-09-2017 | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-07-2002 | 01-06-2010 |
Opleiding van Gavin MacBeath
| University of Manitoba | Undergraduate Degree |
| The Scripps Research Institute | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Canada | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
- Beurs
- Insiders
- Gavin MacBeath
- Ervaring
